On August 3, 2025, Bio Protocol launched its V2 phase, presenting updated tokenomics that include changes to the team token unlock schedule.
Bio Protocol Tokenomics Update
With the V2 launch, Bio Protocol announced updates to its tokenomics, focusing on the gradual release of team and advisor tokens. These changes aim to mitigate market impact from simultaneous token unlocks.
New Token Unlock Schedule
The token unlock schedule has been changed to a linear release, meaning that 4.23% of the total BIO supply will be unlocked over six months, from November 2025 to May 2026, instead of a one-time release.
Market Impact Outlook
Analysts believe that this move may help stabilize BIO's market fluctuations by alleviating sell pressure. Bio Protocol has raised over $29.9 million in funding to date, with no official comments from leadership regarding the V2 launch and updated tokenomics.
The launch of Bio Protocol's V2 phase with updated tokenomics and a restructured token unlock schedule represents a strategic initiative aimed at reducing market volatility, potentially benefiting the entire ecosystem.
